Immunosuppression minimization in kidney transplantation.

Area of Science:

• Nephrology
• Transplantation Immunology

Background:

• Kidney transplantation is the optimal treatment for end-stage renal failure.
• Long-term immunosuppression is necessary but carries risks like cancer and infection.
• Current immunosuppressors cause significant side effects, limiting long-term use.

Purpose of the Study:

• To review studies on minimizing or avoiding corticosteroids and calcineurin inhibitors in kidney transplant recipients.
• To evaluate the safety and efficacy of reduced immunosuppression strategies.
• To discuss the challenges and future directions in personalized immunosuppression.

Main Methods:

• Systematic review of numerous studies on corticosteroid and calcineurin inhibitor minimization, withdrawal, and avoidance.
• Analysis of reported survival and tolerance profiles from different centers.
• Evaluation of existing data regarding adverse events and long-term complications.

Main Results:

• Evidence is mixed, with some studies showing good results and others reporting poor outcomes.
• Lack of long-term follow-up in randomized trials complicates definitive conclusions.
• Corticosteroids and calcineurin inhibitors are major contributors to adverse events post-transplant.

Conclusions:

• Avoiding or minimizing corticosteroids and/or calcineurin inhibitors appears feasible and safe for many kidney transplant patients.
• Personalized treatment strategies, guided by protocol biopsies and immunological tests, are crucial.
• Further long-term randomized studies are needed to establish clear guidelines for immunosuppression management.